Cancer Immune Therapy: Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer

Neelam Mukherjee; Robert Svatek

doi:10.1245/s10434-018-6610-7

Cancer Immune Therapy: Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer

Neelam Mukherjee, Robert Svatek

Department of Urology

Producción científica: Editorial › revisión exhaustiva

8 Citas (Scopus)

Idioma original	English (US)
Páginas (desde-hasta)	2498-2499
Número de páginas	2
Publicación	Annals of Surgical Oncology
Volumen	25
N.º	9
DOI	https://doi.org/10.1245/s10434-018-6610-7
Estado	Published - sept 1 2018

ASJC Scopus subject areas

Surgery
Oncology

Acceder al documento

10.1245/s10434-018-6610-7

Otros archivos y enlaces

Citar esto

@article{0bd20166ef6a44d68eb59926b3acafc6,

title = "Cancer Immune Therapy: Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer",

author = "Neelam Mukherjee and Robert Svatek",

year = "2018",

month = sep,

day = "1",

doi = "10.1245/s10434-018-6610-7",

language = "English (US)",

volume = "25",

pages = "2498--2499",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "9",

}

TY - JOUR

T1 - Cancer Immune Therapy

T2 - Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer

AU - Mukherjee, Neelam

AU - Svatek, Robert

PY - 2018/9/1

Y1 - 2018/9/1

UR - http://www.scopus.com/inward/record.url?scp=85049552337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049552337&partnerID=8YFLogxK

U2 - 10.1245/s10434-018-6610-7

DO - 10.1245/s10434-018-6610-7

M3 - Editorial

C2 - 29971674

AN - SCOPUS:85049552337

SN - 1068-9265

VL - 25

SP - 2498

EP - 2499

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 9

ER -